Recruiting

A Multicenter, Randomized, Double-Blind, Positive Drug-Controlled Study of Qianggan Capsule in the Treatment of MASH with Damp-Heat Stagnation Syndrome

Sponsor
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Enrollment
112 planned
Conditions
Metabolic Associated Fatty Liver Disease; MA51
Interventions
Qianggan Capsule; Vitamin E
Ages
adults, older adults
Registry
ITMCTR2026002341

Full record on ITMCTRSource: WHO ICTRP, processed October 5, 2026

Primary outcomes

  • Proportion of subjects with MASH resolution
  • Changes in serological markers of liver injury;

History

  1. Last registry update

  2. Registered

  3. Started